Orthopaedic & Rheumatologic Institute Outcomes
Surgical Quality Improvement
Orthopaedic Surgery Outcomes
Orthopaedic Surgery ACS NSQIP Outcomes
January 1, 2024 – December 31, 2024
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall orthopaedic surgery ACS NSQIP performance benchmarked against 309 participating sites.
| Orthopaedic Surgery (309 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Mortality | 465 | 0.00% | 0.31% |
| 30 Day Morbidity | 465 | 3.23% | 3.93% |
| Cardiac | 465 | 0.43% | 0.34% |
| Pneumonia | 465 | 0.22% | 0.40% |
| Unplanned Intubation | 465 | 0.22% | 0.13% |
| Ventilator > 48 Hours | 465 | 0.22% | 0.07% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 465 | 0.86% | 0.87% |
| Renal Failure | 465 | 0.65% | 0.65% |
| Urinary Tract Infection (UTI) | 465 | 0.65% | 0.69% |
| Surgical Site Infection (SSI) | 465 | 0.86% | 1.76% |
| Sepsis | 465 | 0.43% | 0.43% |
| C.diff Colitis | 465 | 0.00% | 0.06% |
| Unplanned Reoperation | 465 | 1.51% | 2.03% |
| Unplanned Readmission | 465 | 3.87% | 4.36% |
American College of Surgeons National Surgical Quality Improvement Program, 2025.
ACS NSQIP® Semiannual Report July, 2025, Chicago: American College of Surgeons.
